HIGH

Lupin Pharmaceuticals Recalls Sertraline Hydrochloride Tablets for Defective Seal

Lupin Pharmaceuticals recalled 52,128 bottles of Sertraline Hydrochloride Tablets on November 5, 2025. Consumers reported issues with defective seals that do not adhere to the bottles. The recall follows a Class II classification due to potential contamination risks.

Quick Facts at a Glance

Recall Date
November 5, 2025
Hazard Level
HIGH
Brands
SERTRALINE HYDROCHLORIDE, Lupin Pharmaceuticals, Inc.
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

Defective container - seal not adhering to bottles

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Lupin Pharmaceuticals Inc. or your healthcare provider for guidance. Notification method: Letter

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

About This Product

Sertraline Hydrochloride Tablets are prescribed to treat depression, anxiety, and other mood disorders. Patients typically use this medication daily as part of their treatment regimen.

Why This Is Dangerous

The seal on the bottles may not adhere properly, risking exposure to contaminants that could compromise the integrity of the medication.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

Consumers who rely on Sertraline for mental health treatment face potential safety risks. The recall may cause inconvenience and necessitate obtaining replacements.

Practical Guidance

How to identify if yours is affected

  1. Check the lot number on your bottle against the recall notice.
  2. Confirm the expiration date is February 2028.
  3. Contact your healthcare provider for further instructions.

Where to find product info

The lot number and expiration date can usually be found on the bottom or side of the bottle.

What timeline to expect

Expect processing for refunds or replacements to take 4 to 6 weeks.

If the manufacturer is unresponsive

  • Follow up with customer service via phone or email.
  • Document all communication attempts.

How to prevent similar issues

  • Always check for recalls on medications before use.
  • Inspect packaging for any visible defects or damage before purchasing.
  • Consult with your pharmacist about medication safety.

Documentation advice

Keep receipts, correspondence regarding the recall, and photographs of the affected product.

Product Details

The recall involves Sertraline Hydrochloride Tablets USP, 100 mg, in 90-tablet bottles. Lot number QB00865 with an expiration date of February 2028 is affected. The product was distributed nationwide.

Key Facts

  • Recall date: November 5, 2025
  • Quantity recalled: 52,128 bottles
  • Lot number: QB00865, exp. date: Feb 2028
  • Class II recall due to high hazard risk

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
Lot # QB00865
exp. date Feb 2028
UPC Codes
68180-351
68180-352
68180-353
+13 more
Affected States
ALL
Report Date
December 17, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Vehicles & Parts
HIGH

Mazda CX-70 Recall 2025 for Powertrain Control Module Software May Lose Drive Power

Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.

Mazda
Loss of
Read more
Vehicles & Parts
HIGH

Nissan Kicks 2025 Certification Label Recall for GVWR/GAWR Errors (PD136, PMA47)

Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.

Nissan
An overloaded
Read more